Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Carotid Intima-media Thickness Measurements: Relations with Atherosclerosis, Risk of Cardiovascular Disease and Application in Randomized Controlled Trials.

Bots ML, Evans GW, Tegeler CH, Meijer R.

Chin Med J (Engl). 2016 Jan 20;129(2):215-26. doi: 10.4103/0366-6999.173500. Review.

2.

Effects of exercise training on carotid intima-media thickness in patients with type 2 diabetes and coronary artery disease. Influence of carotid plaques.

Byrkjeland R, Stensæth KH, Anderssen S, Njerve IU, Arnesen H, Seljeflot I, Solheim S.

Cardiovasc Diabetol. 2016 Jan 22;15:13. doi: 10.1186/s12933-016-0336-2.

3.

Causes of changes in carotid intima-media thickness: a literature review.

Qu B, Qu T.

Cardiovasc Ultrasound. 2015 Dec 15;13:46. doi: 10.1186/s12947-015-0041-4. Review.

4.

Nonalcoholic fatty liver disease and the heart in children and adolescents.

Pacifico L, Chiesa C, Anania C, De Merulis A, Osborn JF, Romaggioli S, Gaudio E.

World J Gastroenterol. 2014 Jul 21;20(27):9055-71. doi: 10.3748/wjg.v20.i27.9055.

5.

National Drug Formulary review of statin therapeutic group using the multiattribute scoring tool.

Ramli A, Aljunid SM, Sulong S, Md Yusof FA.

Ther Clin Risk Manag. 2013;9:491-504. doi: 10.2147/TCRM.S52078. Epub 2013 Dec 4.

6.

Combined effects of aerobic exercise and diet on lipids and lipoproteins in overweight and obese adults: a meta-analysis.

Kelley GA, Kelley KS, Roberts S, Haskell W.

J Obes. 2012;2012:985902. doi: 10.1155/2012/985902. Epub 2012 Mar 4.

7.

Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins.

Danaei G, Tavakkoli M, Hernán MA.

Am J Epidemiol. 2012 Feb 15;175(4):250-62. doi: 10.1093/aje/kwr301. Epub 2012 Jan 5. Review.

8.

Impact of exercise training on arterial wall thickness in humans.

Thijssen DH, Cable NT, Green DJ.

Clin Sci (Lond). 2012 Apr;122(7):311-22. doi: 10.1042/CS20110469. Review.

9.

Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis.

Tonelli M, Lloyd A, Clement F, Conly J, Husereau D, Hemmelgarn B, Klarenbach S, McAlister FA, Wiebe N, Manns B; Alberta Kidney Disease Network.

CMAJ. 2011 Nov 8;183(16):E1189-202. doi: 10.1503/cmaj.101280. Epub 2011 Oct 11. Review.

10.

Statins for the primary prevention of cardiovascular disease.

Taylor F, Ward K, Moore TH, Burke M, Davey Smith G, Casas JP, Ebrahim S.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD004816. doi: 10.1002/14651858.CD004816.pub4. Review. Update in: Cochrane Database Syst Rev. 2013;1:CD004816.

11.

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials.

Brugts JJ, Yetgin T, Hoeks SE, Gotto AM, Shepherd J, Westendorp RG, de Craen AJ, Knopp RH, Nakamura H, Ridker P, van Domburg R, Deckers JW.

BMJ. 2009 Jun 30;338:b2376. doi: 10.1136/bmj.b2376. Review.

Supplemental Content

Support Center